PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32568522-0	2020	A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL.	nimbolide	2-11	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	68-75	
32568522-5	2020	We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or in some cases inactivity.	nimbolide	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	65-72	
32568522-5	2020	We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or in some cases inactivity.	nimbolide	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	136-143	
32568522-5	2020	We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or in some cases inactivity.	nimbolide	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	149-154	
32568522-5	2020	We demonstrate that a PROTAC linking nimbolide to the kinase and BCR-ABL fusion oncogene inhibitor dasatinib, BT1, selectively degrades BCR-ABL over c-ABL in leukemia cancer cells, compared to previously reported cereblon or VHL-recruiting BCR-ABL degraders that show opposite selectivity or in some cases inactivity.	nimbolide	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	136-143